Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2020	85,391,338
Redeemable convertible preferred stock, beginning balance at Dec. 31, 2020	$ 274,104
Increase (Decrease) in Temporary Equity [Roll Forward]
Exercise of Series A-1 redeemable convertible preferred stock warrants (in shares)	12,595
Exercise of Series A-1 redeemable convertible preferred stock warrants	$ 163
Redeemable convertible preferred stock, ending balance balance (in shares) at Jun. 30, 2021	85,403,933
Redeemable convertible preferred stock, ending balance at Jun. 30, 2021	$ 274,267
Beginning balance (in shares) at Dec. 31, 2020		35,627,503
Beginning balance at Dec. 31, 2020	(260,685)	$ 0	$ 117,818	$ 0	$ (378,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	16,934		16,934
Exercise of stock options (in shares)		1,896,030
Exercise of stock options	6,360		6,360
Cumulative translation adjustment	0
Net loss	(29,380)				(29,380)
Ending balance (in shares) at Jun. 30, 2021		37,523,533
Ending balance at Jun. 30, 2021	$ (266,771)	$ 0	141,112	0	(407,883)
Redeemable convertible preferred stock, beginning balance (in shares) at Mar. 31, 2021	85,403,933
Redeemable convertible preferred stock, beginning balance at Mar. 31, 2021	$ 274,267
Redeemable convertible preferred stock, ending balance balance (in shares) at Jun. 30, 2021	85,403,933
Redeemable convertible preferred stock, ending balance at Jun. 30, 2021	$ 274,267
Beginning balance (in shares) at Mar. 31, 2021		37,085,703
Beginning balance at Mar. 31, 2021	(263,414)	$ 0	133,078	0	(396,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	6,372		6,372
Exercise of stock options (in shares)		437,830
Exercise of stock options	1,662		1,662
Cumulative translation adjustment	0
Net loss	(11,391)				(11,391)
Ending balance (in shares) at Jun. 30, 2021		37,523,533
Ending balance at Jun. 30, 2021	$ (266,771)	$ 0	141,112	0	(407,883)
Redeemable convertible preferred stock, beginning balance (in shares) at Dec. 31, 2021	0
Redeemable convertible preferred stock, beginning balance at Dec. 31, 2021	$ 0
Redeemable convertible preferred stock, ending balance balance (in shares) at Jun. 30, 2022	0
Redeemable convertible preferred stock, ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021		139,164,693
Beginning balance at Dec. 31, 2021	389,700	$ 1	848,229	(1)	(458,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	31,029		31,029
Exercise of stock options (in shares)		846,284
Exercise of stock options	3,634		3,634
Vesting of restricted stock units (in shares)		85,206
Vesting of restricted stock units	67		67
Issuances of common stock under employee stock purchase plan (in shares)		526,754
Issuance of common stock under employee stock purchase plan	5,563		5,563
Cumulative translation adjustment	(18)			(18)
Net loss	(55,029)				(55,029)
Ending balance (in shares) at Jun. 30, 2022		140,622,937
Ending balance at Jun. 30, 2022	$ 374,946	$ 1	888,522	(19)	(513,558)
Redeemable convertible preferred stock, beginning balance (in shares) at Mar. 31, 2022	0
Redeemable convertible preferred stock, beginning balance at Mar. 31, 2022	$ 0
Redeemable convertible preferred stock, ending balance balance (in shares) at Jun. 30, 2022	0
Redeemable convertible preferred stock, ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Mar. 31, 2022		139,573,416
Beginning balance at Mar. 31, 2022	380,508	$ 1	864,676	9	(484,178)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	16,097		16,097
Exercise of stock options (in shares)		469,706
Exercise of stock options	2,119		2,119
Vesting of restricted stock units (in shares)		53,061
Vesting of restricted stock units	67		67
Issuances of common stock under employee stock purchase plan (in shares)		526,754
Issuance of common stock under employee stock purchase plan	5,563		5,563
Cumulative translation adjustment	(28)			(28)
Net loss	(29,380)				(29,380)
Ending balance (in shares) at Jun. 30, 2022		140,622,937
Ending balance at Jun. 30, 2022	$ 374,946	$ 1	$ 888,522	$ (19)	$ (513,558)